US Stock MarketDetailed Quotes

BASI Bioanalytical Systems

Watchlist
  • 0.000
  • 0.0000.00%
Trading Dec 12 09:30 ET
0Market Cap0.00P/E (TTM)

Bioanalytical Systems Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
(Q1)Dec 31, 2021
(FY)Sep 30, 2021
(Q4)Sep 30, 2021
(Q3)Jun 30, 2021
(Q2)Mar 31, 2021
(Q1)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-148.55%-5.22M
-93.66%171K
-367.24%-9.42M
79.89%5.17M
-169.19%-1.14M
733.02%10.75M
1,011.15%2.7M
184.11%3.52M
359.86%2.87M
13.77%1.65M
Net income from continuing operations
-3,195.57%-337.26M
-2,696.79%-243.63M
-236.66%-3.56M
-821.72%-6.66M
-22,689.89%-83.41M
332.55%10.9M
623.55%9.38M
396.02%2.6M
-22.96%-723K
74.33%-366K
Operating gains losses
535.87%57.59M
--865K
---691K
-24,600.00%-247K
640,611.11%57.66M
---13.21M
----
----
92.31%-1K
-50.00%9K
Depreciation and amortization
686.92%49.32M
700.41%17.46M
727.78%16M
802.75%9.83M
466.67%6.04M
53.85%6.27M
64.36%2.18M
79.98%1.93M
15.73%1.09M
45.49%1.07M
Deferred tax
-257.77%-17.84M
-7,908.47%-9.45M
-33.10%-6.48M
--12.37M
---14.28M
---4.99M
---118K
---4.87M
--0
--0
Other non cash items
10,874.24%21.73M
26,350.00%2.12M
49,140.00%7.39M
11,040.63%7.13M
4,491.89%5.1M
-10.41%198K
-55.56%8K
117.44%15K
-66.32%64K
12.12%111K
Change In working capital
-520.03%-40.28M
-261.92%-5.75M
-839.88%-24.34M
-966.85%-18.78M
1,381.72%8.59M
898.85%9.59M
1,210.31%3.55M
201.56%3.29M
223.14%2.17M
-70.23%580K
-Change in receivables
-99.46%-23.84M
184.71%6.73M
-938.84%-21.64M
-707.66%-10.44M
339.27%1.52M
-1,827.58%-11.95M
-9,903.70%-7.94M
-277.73%-2.08M
-50.35%-1.29M
37.41%-634K
-Change in inventory
-36,016.33%-35.2M
-2,395.73%-8.61M
-11,234.29%-11.9M
-282,475.00%-11.3M
-1,827.84%-3.39M
-75.19%98K
-52.53%375K
63.29%-105K
102.35%4K
-388.52%-176K
-Change in prepaid assets
-2,471.03%-20.05M
-580.90%-5.31M
-2,480.90%-4.59M
-2,231.30%-8.72M
-519.91%-1.43M
32.11%-780K
---780K
---178K
701.96%409K
70.16%-231K
-Change in payables and accrued expense
-14.27%6.62M
-62.30%1.82M
437.31%11.09M
-185.31%-1.24M
-712.40%-5.05M
487.46%7.72M
1,211.06%4.82M
411.78%2.06M
170.39%1.46M
-152.94%-621K
-Change in other working capital
122.02%32.19M
-105.34%-378K
-24.78%2.7M
713.22%12.92M
655.89%16.95M
235.11%14.5M
1,705.36%7.08M
2,394.44%3.59M
23.18%1.59M
-10.36%2.24M
Cash from discontinued investing activities
Operating cash flow
-148.55%-5.22M
-93.66%171K
-367.24%-9.42M
79.89%5.17M
-169.19%-1.14M
733.02%10.75M
1,011.15%2.7M
184.11%3.52M
359.86%2.87M
13.77%1.65M
Investing cash flow
Cash flow from continuing investing activities
-517.32%-333.72M
-211.53%-15.6M
68.89%-14.51M
-7,389.80%-71.23M
-15,666.15%-232.39M
-433.61%-54.06M
-382.74%-5.01M
-2,575.22%-46.63M
24.22%-951K
75.82%-1.47M
Capital expenditure reported
-191.05%-36.3M
-22.14%-5.03M
-171.00%-16.07M
-901.78%-9.55M
-283.65%-5.66M
-101.16%-12.47M
-271.97%-4.11M
-240.28%-5.93M
19.65%-953K
31.92%-1.47M
Net PPE purchase and sale
14,400.00%290K
--13K
---6K
-150.00%-1K
--284K
--2K
--0
--0
--2K
--0
Net business purchase and sale
-615.83%-297.71M
-1,086.43%-10.58M
103.87%1.57M
---61.68M
---227.02M
-958.00%-41.59M
-1,392.75%-892K
---40.7M
--0
--0
Cash from discontinued investing activities
Investing cash flow
-517.32%-333.72M
-211.53%-15.6M
68.89%-14.51M
-7,389.80%-71.23M
-15,666.15%-232.39M
-433.61%-54.06M
-382.74%-5.01M
-2,575.22%-46.63M
24.22%-951K
75.82%-1.47M
Financing cash flow
Cash flow from continuing financing activities
2.17%203.15M
-89.60%13.99M
-102.09%-1.37M
8,066.93%71.07M
27,947.55%119.47M
1,962.36%198.83M
64,489.00%134.57M
1,915.99%65.58M
-143.55%-892K
-109.43%-429K
Net issuance payments of debt
37.49%214.26M
-89.22%15.13M
-107.09%-1.2M
4,627.85%73.8M
52,837.66%126.52M
1,499.65%155.84M
72,435.05%140.33M
420.29%16.9M
-180.34%-1.63M
-94.87%239K
Net common stock issuance
--0
--0
----
----
----
--48.97M
---1K
----
----
----
Proceeds from stock option exercised by employees
-52.03%118K
-72.41%16K
-88.31%9K
-31.34%46K
6.82%47K
846.15%246K
5,700.00%58K
1,440.00%77K
235.00%67K
--44K
Net other financing activities
-80.36%-11.22M
80.10%-1.16M
51.09%-180K
-515.05%-2.79M
-897.47%-7.1M
-4,800.00%-6.22M
-36,237.50%-5.81M
---368K
67,200.00%671K
-547.27%-712K
Cash from discontinued financing activities
Financing cash flow
2.17%203.15M
-89.60%13.99M
-102.09%-1.37M
8,066.93%71.07M
27,947.55%119.47M
1,962.36%198.83M
64,489.00%134.57M
1,915.99%65.58M
-143.55%-892K
-109.43%-429K
Net cash flow
Beginning cash position
11,061.02%156.92M
-11.93%21.72M
2,071.50%47.47M
3,610.30%42.85M
11,061.02%156.92M
132.01%1.41M
736.50%24.66M
1,004.04%2.19M
126.03%1.16M
132.01%1.41M
Current changes in cash
-187.31%-135.79M
-101.08%-1.44M
-212.53%-25.29M
385.65%5.01M
-45,346.22%-114.07M
19,339.75%155.52M
8,677.43%132.26M
717.24%22.47M
429.39%1.03M
-164.21%-251K
Effect of exchange rate changes
---2.16M
---1.3M
---460K
---392K
--0
--0
--0
--0
--0
--0
End cash Position
-87.90%18.98M
-87.90%18.98M
-11.93%21.72M
2,071.50%47.47M
3,610.30%42.85M
11,061.02%156.92M
11,061.02%156.92M
736.50%24.66M
1,004.04%2.19M
126.03%1.16M
Free cash flow
-2,305.39%-41.52M
-242.55%-4.85M
-958.47%-25.49M
-327.85%-4.38M
-3,919.10%-6.8M
64.85%-1.73M
-1.07%-1.42M
-378.73%-2.41M
183.81%1.92M
124.96%178K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022(Q1)Dec 31, 2021(FY)Sep 30, 2021(Q4)Sep 30, 2021(Q3)Jun 30, 2021(Q2)Mar 31, 2021(Q1)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -148.55%-5.22M-93.66%171K-367.24%-9.42M79.89%5.17M-169.19%-1.14M733.02%10.75M1,011.15%2.7M184.11%3.52M359.86%2.87M13.77%1.65M
Net income from continuing operations -3,195.57%-337.26M-2,696.79%-243.63M-236.66%-3.56M-821.72%-6.66M-22,689.89%-83.41M332.55%10.9M623.55%9.38M396.02%2.6M-22.96%-723K74.33%-366K
Operating gains losses 535.87%57.59M--865K---691K-24,600.00%-247K640,611.11%57.66M---13.21M--------92.31%-1K-50.00%9K
Depreciation and amortization 686.92%49.32M700.41%17.46M727.78%16M802.75%9.83M466.67%6.04M53.85%6.27M64.36%2.18M79.98%1.93M15.73%1.09M45.49%1.07M
Deferred tax -257.77%-17.84M-7,908.47%-9.45M-33.10%-6.48M--12.37M---14.28M---4.99M---118K---4.87M--0--0
Other non cash items 10,874.24%21.73M26,350.00%2.12M49,140.00%7.39M11,040.63%7.13M4,491.89%5.1M-10.41%198K-55.56%8K117.44%15K-66.32%64K12.12%111K
Change In working capital -520.03%-40.28M-261.92%-5.75M-839.88%-24.34M-966.85%-18.78M1,381.72%8.59M898.85%9.59M1,210.31%3.55M201.56%3.29M223.14%2.17M-70.23%580K
-Change in receivables -99.46%-23.84M184.71%6.73M-938.84%-21.64M-707.66%-10.44M339.27%1.52M-1,827.58%-11.95M-9,903.70%-7.94M-277.73%-2.08M-50.35%-1.29M37.41%-634K
-Change in inventory -36,016.33%-35.2M-2,395.73%-8.61M-11,234.29%-11.9M-282,475.00%-11.3M-1,827.84%-3.39M-75.19%98K-52.53%375K63.29%-105K102.35%4K-388.52%-176K
-Change in prepaid assets -2,471.03%-20.05M-580.90%-5.31M-2,480.90%-4.59M-2,231.30%-8.72M-519.91%-1.43M32.11%-780K---780K---178K701.96%409K70.16%-231K
-Change in payables and accrued expense -14.27%6.62M-62.30%1.82M437.31%11.09M-185.31%-1.24M-712.40%-5.05M487.46%7.72M1,211.06%4.82M411.78%2.06M170.39%1.46M-152.94%-621K
-Change in other working capital 122.02%32.19M-105.34%-378K-24.78%2.7M713.22%12.92M655.89%16.95M235.11%14.5M1,705.36%7.08M2,394.44%3.59M23.18%1.59M-10.36%2.24M
Cash from discontinued investing activities
Operating cash flow -148.55%-5.22M-93.66%171K-367.24%-9.42M79.89%5.17M-169.19%-1.14M733.02%10.75M1,011.15%2.7M184.11%3.52M359.86%2.87M13.77%1.65M
Investing cash flow
Cash flow from continuing investing activities -517.32%-333.72M-211.53%-15.6M68.89%-14.51M-7,389.80%-71.23M-15,666.15%-232.39M-433.61%-54.06M-382.74%-5.01M-2,575.22%-46.63M24.22%-951K75.82%-1.47M
Capital expenditure reported -191.05%-36.3M-22.14%-5.03M-171.00%-16.07M-901.78%-9.55M-283.65%-5.66M-101.16%-12.47M-271.97%-4.11M-240.28%-5.93M19.65%-953K31.92%-1.47M
Net PPE purchase and sale 14,400.00%290K--13K---6K-150.00%-1K--284K--2K--0--0--2K--0
Net business purchase and sale -615.83%-297.71M-1,086.43%-10.58M103.87%1.57M---61.68M---227.02M-958.00%-41.59M-1,392.75%-892K---40.7M--0--0
Cash from discontinued investing activities
Investing cash flow -517.32%-333.72M-211.53%-15.6M68.89%-14.51M-7,389.80%-71.23M-15,666.15%-232.39M-433.61%-54.06M-382.74%-5.01M-2,575.22%-46.63M24.22%-951K75.82%-1.47M
Financing cash flow
Cash flow from continuing financing activities 2.17%203.15M-89.60%13.99M-102.09%-1.37M8,066.93%71.07M27,947.55%119.47M1,962.36%198.83M64,489.00%134.57M1,915.99%65.58M-143.55%-892K-109.43%-429K
Net issuance payments of debt 37.49%214.26M-89.22%15.13M-107.09%-1.2M4,627.85%73.8M52,837.66%126.52M1,499.65%155.84M72,435.05%140.33M420.29%16.9M-180.34%-1.63M-94.87%239K
Net common stock issuance --0--0--------------48.97M---1K------------
Proceeds from stock option exercised by employees -52.03%118K-72.41%16K-88.31%9K-31.34%46K6.82%47K846.15%246K5,700.00%58K1,440.00%77K235.00%67K--44K
Net other financing activities -80.36%-11.22M80.10%-1.16M51.09%-180K-515.05%-2.79M-897.47%-7.1M-4,800.00%-6.22M-36,237.50%-5.81M---368K67,200.00%671K-547.27%-712K
Cash from discontinued financing activities
Financing cash flow 2.17%203.15M-89.60%13.99M-102.09%-1.37M8,066.93%71.07M27,947.55%119.47M1,962.36%198.83M64,489.00%134.57M1,915.99%65.58M-143.55%-892K-109.43%-429K
Net cash flow
Beginning cash position 11,061.02%156.92M-11.93%21.72M2,071.50%47.47M3,610.30%42.85M11,061.02%156.92M132.01%1.41M736.50%24.66M1,004.04%2.19M126.03%1.16M132.01%1.41M
Current changes in cash -187.31%-135.79M-101.08%-1.44M-212.53%-25.29M385.65%5.01M-45,346.22%-114.07M19,339.75%155.52M8,677.43%132.26M717.24%22.47M429.39%1.03M-164.21%-251K
Effect of exchange rate changes ---2.16M---1.3M---460K---392K--0--0--0--0--0--0
End cash Position -87.90%18.98M-87.90%18.98M-11.93%21.72M2,071.50%47.47M3,610.30%42.85M11,061.02%156.92M11,061.02%156.92M736.50%24.66M1,004.04%2.19M126.03%1.16M
Free cash flow -2,305.39%-41.52M-242.55%-4.85M-958.47%-25.49M-327.85%-4.38M-3,919.10%-6.8M64.85%-1.73M-1.07%-1.42M-378.73%-2.41M183.81%1.92M124.96%178K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Salesforce
CRM
+1.13%
Cisco
CSCO
+1.07%
Microsoft
MSFT
+0.96%
Apple
AAPL
+0.69%
Alibaba
BABA
+0.53%

Unlock the Full List